Cullinan Oncology Inc.

NASDAQ: CGEM · Real-Time Price · USD
7.67
0.09 (1.19%)
At close: Aug 15, 2025, 3:59 PM
7.66
-0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Cullinan Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 18.94M
Cost of Revenue
77K 76K 77K 76K 77K 76K 77K 80K 81K 72K 59K 9K n/a n/a 12K 13K n/a n/a
Gross Profit
-77K -76K -77K -76K -77K -76K -77K -80K -81K -72K -59K -9K n/a n/a -37.86M -13K -13K 18.94M
Operating Income
-75.8M -55M -55.05M -48.85M -50.03M -42.99M -45.48M -45.24M -37.6M -62.76M -32.61M -29.77M 239.68M -32.66M -34.35M -18.38M -16.6M 1.37M
Interest Income
5.92M 6.58M 7.51M 8.38M 8.07M 5.69M 5.92M 5.88M 5.32M 4.51M 3.36M 2.35M 697K 197K 137K 118K 173K 49K
Pretax Income
-70.06M -48.5M -47.53M -40.56M -42.03M -37.34M -39.69M -39.18M -32.21M -58.14M -28.95M -27.41M 240.13M -32.46M -34.21M -18.26M -16.44M 1.42M
Net Income
-70.06M -48.5M -47.65M -40.56M -42.03M -37.15M -23.8M -39.18M -32.21M -57.96M -26.78M -24.8M 174.9M -12.1M -32.51M -17.35M -15.64M -70K
Selling & General & Admin
14.77M 13.54M 14.56M 13.35M 13.69M 12.27M 10.56M 10.98M 10.21M 10.66M 11.29M 10.09M 10.7M 8.12M 13.47M 5.7M 4.83M 5.16M
Research & Development
61.03M 41.46M 40.49M 35.51M 36.26M 30.65M 34.85M 33.82M 27.39M 52.1M 21.32M 19.68M 26.41M 24.54M 20.88M 12.68M 11.78M 12.41M
Other Expenses
n/a n/a -77K n/a n/a n/a n/a 440K 69K 107K 298K n/a -241K n/a 4K -2K -8K -2K
Operating Expenses
75.8M 55M 54.97M 48.85M 49.95M 42.91M 45.41M 45.24M 37.6M 62.76M 32.61M 29.77M 37.11M 32.66M 34.35M 18.38M 16.6M 17.57M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -77K -76K -77K n/a n/a n/a n/a n/a n/a n/a 600K n/a n/a n/a
Cost & Expenses
75.8M 55M 55.05M 48.85M 50.03M 42.99M 45.48M 45.24M 37.6M 62.76M 32.61M 29.77M 37.11M 32.66M 34.35M 18.38M 16.6M 17.57M
Income Tax Expense
n/a n/a 117K n/a n/a -192K -14.12M n/a n/a -179K -1.86M -2.52M 66.07M -19.57M 223K n/a n/a n/a
Shares Outstanding (Basic)
59.02M 58.91M 58.58M 58.34M 55.05M 43.01M 42.79M 42.73M 39.95M 40.68M 45.75M 45.61M 44.87M 44.43M 43.52M 43.44M 43.3M 41.98M
Shares Outstanding (Diluted)
59.02M 58.91M 58.58M 58.34M 55.05M 43.01M 42.79M 42.73M 39.95M 40.68M 45.75M 45.61M 46.38M 44.43M 43.64M 43.44M 43.3M 41.98M
EPS (Basic)
-1.19 -0.82 -0.81 -0.7 -0.76 -0.86 -0.56 -0.92 -0.81 -1.42 -0.59 -0.54 3.90 -0.27 -0.74 -0.4 -0.36 -0.00
EPS (Diluted)
-1.19 -0.82 -0.81 -0.7 -0.76 -0.86 -0.56 -0.92 -0.81 -1.42 -0.59 -0.54 3.77 -0.27 -0.74 -0.4 -0.36 -0.00
EBITDA
-75.8M -54.92M -54.97M -48.78M -49.95M -42.91M -45.41M -44.72M -37.52M -62.68M -32.55M -29.76M -35.39M -32.64M -34.34M -18.36M -16.59M 1.39M
EBIT
-70.06M -55M -47.53M -48.85M -50.03M -42.99M -45.48M -44.8M -37.6M -62.76M -34.61M -29.77M -35.41M -32.66M -34.35M -18.38M -16.6M 1.37M
Depreciation & Amortization
77K 76K 77K 76K 77K 76K 77K 80K 81K 72K 59K 9K 12K 13K 12K 13K 13K 15K